Jonathan Lim, Co-Lead of The Manchester Immuno-Oncology Network (MION) and Lead of The Christie International Fellowship Program for Medical Oncology at The Christie NHS Foundation Trust, shared a post on LinkedIn:
“Grateful to be in Tbilisi for the inaugural International Rare Cancers and Precision Medicine Conference.
Thank you for the invitation to speak about cell therapy for solid tumours, and explore potential opportunities for rare cancers. Although still early in its development, we hope cell therapy might one day be delivered sustainably and equitably.
Fantastic hospitality, and delighted to meet so many engaged residents and medical students too.”
More posts featuring Jonathan Lim on OncoDaily.
